Legal & General Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.3M Sell
1,426,164
-845,459
-37% -$23.3M 0.01% 667
2025
Q1
$64.4M Buy
2,271,623
+114,502
+5% +$3.25M 0.02% 579
2024
Q4
$89.7M Buy
2,157,121
+69,552
+3% +$2.89M 0.02% 527
2024
Q3
$140M Buy
2,087,569
+9,978
+0.5% +$667K 0.04% 429
2024
Q2
$247M Sell
2,077,591
-260,124
-11% -$30.9M 0.07% 287
2024
Q1
$249M Sell
2,337,715
-26,357
-1% -$2.81M 0.07% 282
2023
Q4
$235M Sell
2,364,072
-7,702
-0.3% -$766K 0.07% 290
2023
Q3
$245M Sell
2,371,774
-66,134
-3% -$6.83M 0.09% 256
2023
Q2
$296M Buy
2,437,908
+91,232
+4% +$11.1M 0.1% 222
2023
Q1
$360M Sell
2,346,676
-9,629
-0.4% -$1.48M 0.13% 166
2022
Q4
$423M Sell
2,356,305
-92,509
-4% -$16.6M 0.16% 132
2022
Q3
$290M Sell
2,448,814
-119,997
-5% -$14.2M 0.11% 200
2022
Q2
$367M Buy
2,568,811
+196,408
+8% +$28.1M 0.13% 172
2022
Q1
$409M Buy
2,372,403
+158,518
+7% +$27.3M 0.12% 179
2021
Q4
$562M Buy
2,213,885
+70,143
+3% +$17.8M 0.17% 117
2021
Q3
$825M Buy
2,143,742
+264,633
+14% +$102M 0.27% 71
2021
Q2
$442M Buy
1,879,109
+339,067
+22% +$79.7M 0.15% 145
2021
Q1
$202M Sell
1,540,042
-2,261
-0.1% -$296K 0.08% 306
2020
Q4
$161M Buy
1,542,303
+62,990
+4% +$6.58M 0.06% 342
2020
Q3
$105M Buy
1,479,313
+528,946
+56% +$37.4M 0.05% 409
2020
Q2
$61M Buy
950,367
+775,540
+444% +$49.8M 0.03% 527
2020
Q1
$5.2M Sell
174,827
-78,519
-31% -$2.34M ﹤0.01% 1147
2019
Q4
$4.96M Buy
253,346
+179,048
+241% +$3.5M ﹤0.01% 1371
2019
Q3
$1.18M Buy
74,298
+67,130
+937% +$1.07M ﹤0.01% 1922
2019
Q2
$105K Sell
7,168
-50,421
-88% -$739K ﹤0.01% 2510
2019
Q1
$1.17M Sell
57,589
-20,048
-26% -$407K ﹤0.01% 1916
2018
Q4
$1.18M Buy
+77,637
New +$1.18M ﹤0.01% 1842